 | • レポートコード：B-MOR-08222 • 出版社/出版日：Mordor Intelligence / 2018年5月18日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、頭頸部がん診断の世界市場について調べ、頭頸部がん診断の世界規模、市場動向、市場環境、画像診断装置別（PET、CT、MRI）分析、内視鏡スクリーニング装置別（咽頭鏡検査、喉頭鏡検査、汎内視鏡検査）分析、生検スクリーニング検査別分析、歯科診断法別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・頭頸部がん診断の世界市場インサイト ・頭頸部がん診断の世界市場環境 ・頭頸部がん診断の世界市場動向 ・頭頸部がん診断の世界市場規模 ・頭頸部がん診断の世界市場規模：画像診断装置別（PET、CT、MRI） ・頭頸部がん診断の世界市場規模：内視鏡スクリーニング装置別（咽頭鏡検査、喉頭鏡検査、汎内視鏡検査） ・頭頸部がん診断の世界市場規模：生検スクリーニング検査別 ・頭頸部がん診断の世界市場規模：歯科診断法別 ・頭頸部がん診断の世界市場：地域別市場規模・分析 ・頭頸部がん診断の北米市場規模・予測 ・頭頸部がん診断のアメリカ市場規模・予測 ・頭頸部がん診断のヨーロッパ市場規模・予測 ・頭頸部がん診断のアジア市場規模・予測 ・頭頸部がん診断の日本市場規模・予測 ・頭頸部がん診断の中国市場規模・予測 ・頭頸部がん診断のインド市場規模・予測 ・頭頸部がん診断の韓国市場規模・予測 ・関連企業情報・競争状況 |
Head and neck cancer is among the 10 most common types of cancers worldwide. This form of cancer is especially prevalent in regions having high alcohol and tobacco intake. Early detection and prompt treatment offer the best chance for cure. The global head and neck cancer diagnostics market is expected to register a CAGR of 10.5% during the forecast period of 2018–2023.
Rising Incidences of Target Diseases
The rising incidences in the number of cases of head and neck cancer have always been the major driving factor for this market. It is estimated that nearly 550,000 new cases of head and neck cancer are diagnosed globally, each year. It is estimated that nearly 6% of the malignancies occur in the United States. According to the American Cancer society nearly 40,000 people in the United States were diagnosed with head and neck cancer, of which, around 12,000 died in 2014 alone. This number is estimated to increase if serious measures are not taken. Head and neck cancer account for nearly 5-6% of the cancer cases in the United States alone. It is the 15th most prevalent cancer in Europe, with nearly 56,000 cases diagnosed annually. This huge disease burden will help in the growth of the market.
The rise in geriatric population worldwide, combined with government and private body initiatives are some of the other factors contributing to the growth of the market.
Excise Duty on Sale of Medical Devices in Developed Markets
The excise duty imposed on the medical devices in developed countries is causing a major burden on the manufacturers as well as buyers. The companies manufacturing these devices are constantly trying to remove this excise tax. The investment in medical devices in 2013 fell 17% from the previous year. Also, investment funding is shifting towards less risky later-stage medical device companies instead of smaller earlier stage ventures. These trends are worrisome since early-stage investment companies can promote innovative and disruptive medical device technologies, which introduce new therapeutic benefits or quantum improvements in patient care.
Additionally, low adoption rate in patients for digital technology-based systems, such as conventional CT and MRI scanners, is also restraining the head and neck cancer diagnostics market.
Africa and Asia-Pacific to have the Highest Incidence of Head and Neck Cancer
The global head and neck cancer diagnostics market is segmented by diagnostic imaging equipment, endoscopy screening equipment, bioscopy screening tests, dental diagnostic methods, and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
Africa and Asia-Pacific, along with parts of Europe, and certain regions in South America, have the highest incidence of head and neck cancer cases, as these regions are prone to higher intake of alcohol and tobacco products. In Asia-Pacific and Africa, India, China, and South Africa are the biggest markets for the overall head and neck cancer diagnostics market.
Major Players: PHILIPS HEALTHCARE, GE HEALTHCARE, SIEMENS HEALTHCARE, VARIAN MEDICAL SYSTEMS, SHIMADZU CORPORATION, ADDENT, INC., IDENTAFI, and VELSCOPE VX, among others.
Reasons to Purchase the Report
• Market analysis for the head and neck cancer diagnostics market, with region-specific assessments and competition analysis on a global and regional scale.
• Analyzing various perspectives of the industry with the help of Porter’s Five Forces Analysis.
• Identify the treatment type that is expected to dominate the market.
• Identify the regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Drivers
6.1.1 Rise in Incidences of Target Diseases
6.1.2 Rise in Geriatric Population Worldwide
6.1.3 Rise in Government and Private Body Initiatives
6.2 Restraints
6.2.1 Low Adoption Rate in Patients for Digital Technology-Based Systems
6.2.2 Excise Duty Imposed on Sale of Medical Devices in Developed Markets
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 Diagnostic Imaging Equipments
7.1.1 PET
7.1.2 CT
7.1.3 MRI
7.2 Endoscopy Screening Equipments
7.2.1 Pharyngoscopy
7.2.2 Laryngoscopy
7.2.3 Panendoscopy
7.3 Bioscopy Screening Tests
7.3.1 Incisional Biopsy
7.3.2 Fine Needle Aspiration Biopsy
7.3.3 HPV Testing
7.4 Dental Diagnostic Methods
7.4.1 Toluidine Blue Dye-Based Method
7.4.2 Acetic Acid Rinse Method
7.4.3 Brush Biopsy
7.5 By Geography
7.5.1 North America
7.5.1.1 United States
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.1.4 Rest of North America
7.5.2 Europe
7.5.2.1 France
7.5.2.2 United Kingdom
7.5.2.3 Germany
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 India
7.5.3.2 China
7.5.3.3 Japan
7.5.3.4 Australia
7.5.3.5 South Korea
7.5.3.6 Rest of Asia-Pacific
7.5.4 Middle East & Africa
7.5.4.1 Gulf Cooperation Council
7.5.4.2 South Africa
7.5.4.3 Rest of the Middle East & Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Addent, Inc.
9.2 GE Healthcare
9.3 Identafi
9.4 Philips Healthcare
9.5 Shimadzu Corporation
9.6 Siemens Healthcare
9.7 Varian Medical Systems
9.8 Velscope VX
*List not Exhaustive
10. Future of the Market